The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial

M.J. Nahuis; N.S. Weiss; F. van der Veen; B.W.J. Mol; P.G.A. Hompes; J. Oosterhuis; C.B. Lambalk; J.M. Smeenk; C.A. Koks; R.J. van Golde; J.S. Laven; B.J. Cohlen; K. Fleischer; A. J. Goverde; M.H. Gerards; N.F. Klijn; L.C. Nekrui; I.A. van Rooij; D.A. Hoozemans; M. van Wely

doi:10.1186/1472-6874-13-42

The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial

M.J. Nahuis, N.S. Weiss, F. van der Veen, B.W.J. Mol, P.G.A. Hompes, J. Oosterhuis, C.B. Lambalk, J.M. Smeenk, C.A. Koks, R.J. van Golde, J.S. Laven, B.J. Cohlen, K. Fleischer, A. J. Goverde, M.H. Gerards, N.F. Klijn, L.C. Nekrui, I.A. van Rooij, D.A. Hoozemans, M. van Wely

Obstetrics and gynaecology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	42
Journal	BMC Women's Health
Volume	13
DOIs	https://doi.org/10.1186/1472-6874-13-42
Publication status	Published - 2013

Access to Document

10.1186/1472-6874-13-42

Cite this

Nahuis, M. J., Weiss, N. S., van der Veen, F., Mol, B. W. J., Hompes, P. G. A., Oosterhuis, J., Lambalk, C. B., Smeenk, J. M., Koks, C. A., van Golde, R. J., Laven, J. S., Cohlen, B. J., Fleischer, K., Goverde, A. J., Gerards, M. H., Klijn, N. F., Nekrui, L. C., van Rooij, I. A., Hoozemans, D. A., & van Wely, M. (2013). The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial. BMC Women's Health, 13, [42]. https://doi.org/10.1186/1472-6874-13-42

@article{e4b02508da8f4c18b6f6c76725afb674,

title = "The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial",

author = "M.J. Nahuis and N.S. Weiss and {van der Veen}, F. and B.W.J. Mol and P.G.A. Hompes and J. Oosterhuis and C.B. Lambalk and J.M. Smeenk and C.A. Koks and {van Golde}, R.J. and J.S. Laven and B.J. Cohlen and K. Fleischer and Goverde, {A. J.} and M.H. Gerards and N.F. Klijn and L.C. Nekrui and {van Rooij}, I.A. and D.A. Hoozemans and {van Wely}, M.",

year = "2013",

doi = "10.1186/1472-6874-13-42",

language = "Undefined/Unknown",

volume = "13",

journal = "BMC Women's Health",

issn = "1472-6874",

publisher = "BioMed Central",

}

Nahuis, MJ, Weiss, NS, van der Veen, F, Mol, BWJ, Hompes, PGA, Oosterhuis, J, Lambalk, CB, Smeenk, JM, Koks, CA, van Golde, RJ, Laven, JS, Cohlen, BJ, Fleischer, K, Goverde, AJ, Gerards, MH, Klijn, NF, Nekrui, LC, van Rooij, IA, Hoozemans, DA & van Wely, M 2013, 'The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial', BMC Women's Health, vol. 13, 42. https://doi.org/10.1186/1472-6874-13-42

The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial. / Nahuis, M.J.; Weiss, N.S.; van der Veen, F. et al.

In: BMC Women's Health, Vol. 13, 42, 2013.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial

AU - Nahuis, M.J.

AU - Weiss, N.S.

AU - van der Veen, F.

AU - Mol, B.W.J.

AU - Hompes, P.G.A.

AU - Oosterhuis, J.

AU - Lambalk, C.B.

AU - Smeenk, J.M.

AU - Koks, C.A.

AU - van Golde, R.J.

AU - Laven, J.S.

AU - Cohlen, B.J.

AU - Fleischer, K.

AU - Goverde, A. J.

AU - Gerards, M.H.

AU - Klijn, N.F.

AU - Nekrui, L.C.

AU - van Rooij, I.A.

AU - Hoozemans, D.A.

AU - van Wely, M.

PY - 2013

Y1 - 2013

U2 - 10.1186/1472-6874-13-42

DO - 10.1186/1472-6874-13-42

M3 - Article

C2 - 24160333

VL - 13

JO - BMC Women's Health

JF - BMC Women's Health

SN - 1472-6874

M1 - 42

ER -

Nahuis MJ, Weiss NS, van der Veen F, Mol BWJ, Hompes PGA, Oosterhuis J et al. The M-OVIN study: does switching treatment to FSH and/or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial. BMC Women's Health. 2013;13:42. doi: 10.1186/1472-6874-13-42